16 January 2026 • Research
Researchers at the National Center for Agricultural Utilization Research (USDA) have identified compounds called dadahol A and dadahol B in the roots of industrial hemp. In laboratory tests, fractions containing these compounds reduced the viability of several pediatric cancer cell lines (including neuroblastoma, hepatoblastoma, and Hodgkin's lymphoma).
12 January 2026 • Research
According to a study published in the medical journal Phytomedicine, CBD may have anti-tumor potential. The authors suggest that it increases pressure on certain cancer cells, limiting their ability to adapt. However, these results are preliminary and will need to be confirmed by further research, particularly in humans, before clinical applications can be considered.
19 December 2025 • Unites States
US President Donald Trump has signed an executive order reclassifying cannabis from Schedule I—which includes substances considered most dangerous, such as heroin, LSD, and ecstasy—to Schedule III, alongside prescription drugs such as hydrocodone. This is a major step forward, marking a historic turning point since the United States introduced prohibition on the international stage nearly 100 years ago.
31 October 2025 • International
A law authorizing the cultivation of medical cannabis was passed in 2020, but it was only recently that the law was implemented with the creation of an agency responsible for overseeing this new sector: the Cannabis Cultivation Management Committee. Government authorities hope that this new industry will help support the country's economy.
8 October 2025 • Europe
The Spanish government has passed a decree authorizing the medical use of THC-based drugs, prescribed only by hospital doctors. Priority beneficiaries will be patients suffering from severe epilepsy, spasticity related to multiple sclerosis, nausea due to chemotherapy, or chronic pain resistant to conventional treatments.
1 October 2025 • Europe
The European Union launches Cannapol, a tool developed by the European Union Drugs Agency (EUDA) to support Member States in implementing policies on recreational cannabis.
29 September 2025 • Unites States
In a post on Truth Social, US President Donald Trump recognizes that CBD helps slow the progression of certain diseases and is an alternative to medication for the elderly. This is his strongest statement in favor of cannabis-related products since he took office in January 2025.
18 September 2025 • Unites States
According to a recent report by the New York State Office of Cannabis Management, cumulative sales since legalization now exceed $2 billion, with nearly $1 billion generated since the beginning of the year.
10 September 2025 • Research
Analytical chemists at Stellenbosch University have identified the presence of flavoalkaloids in cannabis leaves, a rare class of phenolic compounds. Phenolics—and flavonoids in particular—are attracting considerable interest in the pharmaceutical industry due to their recognized antioxidant, anti-inflammatory, and anti-carcinogenic properties.
9 September 2025 • Unites States
Between 2021 and 2023, cannabis use among Americans over the age of 65 jumped by 46%. According to a study published in the medical journal JAMA Internal Medicine, there has also been a significant increase in the number of users from high-income households in this age group.
23 June 2025 • International
Costa Ricans can now buy medical cannabis in pharmacies, on presentation of a prescription for conditions such as cancer, fibromyalgia or epilepsy.
23 June 2025 • Canada
Cannabis sales set a new record in April 2025, reaching almost $470 million. Statistics Canada also revised previous months' figures upwards, bringing February sales to $456.4 million and March sales to $462.5 million.
